Catalyst

Slingshot members are tracking this event:

Vanda Pharmaceuticals (VNDA) expecting Phase 2 results for Tradipitant clinical trial, testing treatment for Pruritus, in mid-2017

Source Link:
https://seekingalpha.com/article/4053316-vanda-pharmaceuticals-vnda-presents-cowen-company-37th-annual-health-care-conference

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
VNDA Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details Update on Aug 2 2017: Results are expected in the third quarter of 2017.
http://phx.corporate...
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Sep 13, 2017
Occurred Source:
http://phx.corporate-ir.net/phoenix.zhtml?c=196233&p=irol-newsArticle&ID=2300433
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Pruritus, Phase 2 Clinical Trial Data
About Us
Media Center
Connect with Us
© 2026 Slingshot Insights. All rights reserved.